Breast cancer is the most common cancer in women in the U.S., excludingskin cancers, and is the second leading cause of cancer death in women, though deaths have steadily declined due to earlier detection through screenings and better treatment options. The earlier breast cancer is detected, ...
It is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation, the FDA said on Friday. Patients are selected for treatment with Lynparza based on an FDA-approved genetic test. "This class of drugs has been used to...
if it is, use the therapeutic to impede the tumor's growth and spread. And the possibilities go beyond breast cancer, Sonenshein said. The treatment could be effective for other cancers as well. Scientists have looked for ADAM8 in a variety of solid tumors and in every one of them...
A week after the diagnosis, El-Afandi underwent surgery to remove the tumor. This is standard for glioblastoma treatment, but even after surgery, there's usually cancerous cells left behind because of the way the tumors grow in the brain. That's part of why the mortality rate for glioblasto...
New hope for breast cancer vaccine "GMA" looks at promising results in an early study of a breast cancer vaccine. November 14, 2024 Additional Live Streams Additional Live Streams Live ABC News Live Top Stories By The Numbers: Super Bowl ...
Researchers Suggest New Therapy for BRCA-Related TumorsRead about a new therapy for cancer patients carrying BRCA mutations.Breast Cancer News
These findings suggest promising treatment options while raising important questions about which subgroups would benefit most. Dr Armaghani notes that the discussions and questions sparked by these studies are expected to continue and evolve.
New Survey Reveals 63% of Women Unaware of Increased Breast Cancer Risk Due to Dense Breasts—How Genetic Testing Can Help...
(13%) will be diagnosed with breast cancer in their lifeti... C Nalley - 《Oncology Times》 被引量: 0发表: 2023年 New Combination Shows Early Promise in Gastric Cancer Patients responded relatively well to the phase I trial testing a new treatment for several malignancies, including gastric...
Triple-negative breast cancer (TNBC) remains the most aggressive cluster of all breast cancers, which is due to its rapid progression, high probabilities of early recurrence, and distant metastasis resistant to standard treatment. Following the advances in cancer genomics and transcriptomics that can ...